Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06257537 · ClinicalTrials.gov registry record · Phase 2
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
A Phase 2 study of Osteoarthritis, Knee and Arthritis, sponsored by ZetrOZ.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT06257537: Recruiting Phase 2 study of Osteoarthritis, Knee and Arthritis, sponsored by ZetrOZ.
NCT06257537 is a Phase 2 study of Osteoarthritis, Knee and Arthritis that is actively recruiting participants, run by ZetrOZ. The registered enrollment target is 300 participants, below the 495-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (39% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06257537, a Phase 2 study of Osteoarthritis, Knee and Arthritis, is actively recruiting participants, sponsored by ZetrOZ.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.
Primary Outcome
Change in the self-described pain units on a scale by patient at baseline and post-treatment.
Conditions Studied
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DRUG 2.5% Diclofenac Patches
- DEVICE Sustained Acoustic Device with 0% Diclofenac Patch
- OTHER SAM Patch
Study Locations (3)
Connecticut
- Orthopaedic Foundation - Stamford
- ZetrOZ Systems - Trumbull
New York
- Cayuga Medical Center - Medical Pain Consultants - Dryden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-02-28 |
| Phase | Phase 2 |
What NCT06257537 shows while recruiting
NCT06257537 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 495-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 4 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT06257537 reports a single indexed study location in Connecticut, New York.
Frequently Asked Questions
What is clinical trial NCT06257537 about?
NCT06257537 is a clinical study titled "Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis". The purpose of this study is to assess the ability of long-duration low intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over a 24-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthrit...
What is the current status of trial NCT06257537?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2024-10-01. Estimated completion is 2026-02-28.
What conditions does trial NCT06257537 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee, Arthritis.
What interventions are being tested in trial NCT06257537?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), 2.5% Diclofenac Patches (DRUG), Sustained Acoustic Device with 0% Diclofenac Patch (DEVICE), SAM Patch (OTHER).
Who is sponsoring clinical trial NCT06257537?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06257537 being conducted?
This trial has 3 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06257537's enrollment target sits among peer trials
300 26th of 112 higher than 87 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI